HAS-BLED is a scoring system developed to assess 1-year risk of major bleeding in people taking anticoagulants for AF (atrial fibrillation). Major bleeding is defined as being intracranial bleedings, hospitalization, hemoglobin decrease > 2 g/dL, and/or transfusion.